Skip to main content
Top
Published in: Supportive Care in Cancer 9/2003

01-09-2003 | Original Article

The success of data collection in the palliative setting—telephone or clinic follow-up?

Authors: Peiman Haddad, Paula Wilson, Rebecca Wong, Diane Williams, Neena Sharma, Freidele Soban, Michael McLean, Wilfred Levin, Andrea Bezjak

Published in: Supportive Care in Cancer | Issue 9/2003

Login to get access

Abstract

Assessment of outcomes is essential in order to improve available palliative treatments. Collecting follow-up information can be a challenging task in the palliative setting. We compared the effectiveness of data collection by telephone contact and clinic visit in 112 patients with brain metastases treated with whole-brain radiotherapy. The first 56 patients (group A) were followed by telephone only. The second 56 patients (group B) were asked to attend an outpatient clinic appointment 4 weeks after radiotherapy. Successful contact was defined as obtaining data at week 4. Patients in the two groups did not differ significantly with regard to age, sex, performance status, primary site, number of brain metastases, or the treatment given. The proportions of patients with successful follow-up contact at week 4 were 45% and 61% in groups A and B, respectively (P=0.09). The quality of the collected data did not differ significantly between the two groups. The side effects and responses to therapy were similar. However, there were significantly more patients with a reduced dose of dexamethasone among the successful contacts in group B, which probably reflected the better condition of the patients coming back to clinic at week 4. In conclusion, there was a trend towards more successful data collection in our clinic follow-up. Some of the observed outcome data suggest that the two methods of follow-up might be reaching different populations of patients; considering this and the high attrition rate, a combined follow-up strategy of clinic and telephone contacts might be the best strategy.
Literature
1.
go back to reference Adlard JW, Joseph J, Brammer CV, Gerrard GE (2001) Open access follow-up for lung cancer: patient and staff satisfaction. Clin Oncol (R Coll Radiol) 13:404–408 Adlard JW, Joseph J, Brammer CV, Gerrard GE (2001) Open access follow-up for lung cancer: patient and staff satisfaction. Clin Oncol (R Coll Radiol) 13:404–408
2.
go back to reference Bezjak A, Adam J, Panzarella T, et al (2001) Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 61:71–76CrossRefPubMed Bezjak A, Adam J, Panzarella T, et al (2001) Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 61:71–76CrossRefPubMed
3.
go back to reference Bezjak A, Adam J, Barton R, et al (2002) Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 38:487–496CrossRefPubMed Bezjak A, Adam J, Barton R, et al (2002) Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 38:487–496CrossRefPubMed
4.
go back to reference Brada M, James ND (1995) Follow up by telephone. Phone clinic provides excellent support. BMJ 310:738 Brada M, James ND (1995) Follow up by telephone. Phone clinic provides excellent support. BMJ 310:738
5.
go back to reference Chow E, Wong R, Connolly R, et al (2001) Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up. J Pain Symptom Manage 22:649–656CrossRefPubMed Chow E, Wong R, Connolly R, et al (2001) Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up. J Pain Symptom Manage 22:649–656CrossRefPubMed
6.
go back to reference Gaspar L, Scott C, Rotman M, et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMed Gaspar L, Scott C, Rotman M, et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMed
7.
go back to reference Jordhoy MS, Kaasa S, Fayers P, et al (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized clinical trial. Palliat Med 13:229–310 Jordhoy MS, Kaasa S, Fayers P, et al (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized clinical trial. Palliat Med 13:229–310
8.
9.
go back to reference Rodrigus P, de Brouwer P, Raaymakers E (2001) Brain metastases and non-small cell lung cancer: prognostic factors and correlation with survival after irradiation. Lung Cancer 32:129–136CrossRefPubMed Rodrigus P, de Brouwer P, Raaymakers E (2001) Brain metastases and non-small cell lung cancer: prognostic factors and correlation with survival after irradiation. Lung Cancer 32:129–136CrossRefPubMed
10.
go back to reference Sardell S, Sharpe G, Ashley S, et al (2000) Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol (R Coll Radiol) 12:36–41 Sardell S, Sharpe G, Ashley S, et al (2000) Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol (R Coll Radiol) 12:36–41
11.
go back to reference Sawaya R (2001) Considerations in the diagnosis and management of brain metastases. Oncology (Huntingt) 15:1144–1154 Sawaya R (2001) Considerations in the diagnosis and management of brain metastases. Oncology (Huntingt) 15:1144–1154
Metadata
Title
The success of data collection in the palliative setting—telephone or clinic follow-up?
Authors
Peiman Haddad
Paula Wilson
Rebecca Wong
Diane Williams
Neena Sharma
Freidele Soban
Michael McLean
Wilfred Levin
Andrea Bezjak
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2003
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-003-0485-1

Other articles of this Issue 9/2003

Supportive Care in Cancer 9/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine